Matches 1 - 50 out of 363 1 2 3 4 5 6 7 8 >


Match Document Document Title
US20110020312 METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS  
Methods and formulations for treating metabolic disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.
US20080113000 Compositions and methods for coating medical implants  
Medical implants are provided which release an anthracycline, fluoropyrimidine, folic acid antagonist, podophylotoxin, camptothecin, hydroxyurea, and/or platinum complex, thereby inhibiting or...
US20070184114 Formulation for topical non-invasive application in vivo  
A formulation comprising molecular arrangements capable of penetrating pores in a barrier, owing to penetrant adaptability, despite the fact that the average diameter of said pores is smaller than...
US20070025987 Method for Treating Vasculitis  
A method of treating anti-neutrophil cytoplasmic antibodies-associated vasculitis (ANCA-associated vasculitis) in a patient eligible for treatment is provided involving administering an antagonist...
US20070021357 Treatment of inflammatory conditions  
The invention relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin thereby treating or prevention various diseases, disorders or...
US20070014797 Method for treating Sjogren's syndrome  
A method of treating Sjögren's syndrome in a patient eligible for treatment is provided involving administering an effective amount of an antagonist that binds to a B-cell surface marker to the...
US20060110387 Method for treating vasculitis  
A method of treating anti-neutrophil cytoplasmic antibodies-associated vasculitis (ANCA-associated vasculitis) in a patient eligible for treatment is provided involving administering an antagonist...
US20050158274 Medical implants and fibrosis-inducing agents  
Implants are used in combination with a fibrosis-inducing agent in order to induce fibrosis that may otherwise not occur when the implant is placed within an animal or increase fibrosis between...
US20050147599 Medical implants and fibrosis-inducing agents  
Implants are used in combination with a fibrosis-inducing agent in order to induce fibrosis that may otherwise not occur when the implant is placed within an animal or increase fibrosis between...
US20050147562 Medical implants and fibrosis-inducing agents  
Implants are used in combination with a fibrosis-inducing agent in order to induce fibrosis that may otherwise not occur when the implant is placed within an animal or increase fibrosis between...
US20050119160 Methods and reagents for the treatment of immunoinflammatory disorders  
The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted...
US20120177744 METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR THE TREATMENT OF CANCER  
Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the...
US20090203609 Use of IL-1 inhibitors for treating IL-1 mediated diseases  
The invention relates to methods for treating or preventing arthritis. The method comprises administering to patients in need thereof therapeutically effective amounts of an IL-1 inhibitor and...
US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease  
The present invention includes compositions and methods for the treatment of inflammatory disease (e.g. asthma, COPD, inflammatory bowel disease, atopic dermatitis, atopy, allergy, allergic...
US20080113993 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS  
This invention pertains to active barbituric acid analogs which inhibit HIF-1 activity (e.g., the interaction between HIF-1$g(a) and p300) and thereby inhibit angiogenesis, tumorigenesis, and...
US20070202044 ANTIBODY THERAPY  
The present invention provides a composition comprising naked humanized, chimeric, and human anti-CEA antibodies and a therapeutic agent, which is useful for treatment of CEA expressing cancers...
US20070031331 Treatment of Disorders  
The present invention concerns treatment of polychondritis or mononeuritis multiplex in a mammal with an effective amount of an antibody that binds to CD20, optionally also with another agent that...
US20060240113 Anti-angiogenic compositions and methods of use  
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic...
US20060127438 Compositions and methods for coating medical implants  
Medical implants are provided which release an anthracycline, fluoropyrimidine, folic acid antagonist, podophylotoxin, camptothecin, hydroxyurea, and/or platinum complex, thereby inhibiting or...
US20060034916 Compositions and methods for nutrition supplementation  
The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta...
US20060002930 Treatment of disorders  
The present invention concerns treatment of polychondritis or mononeuritis multiplex in a mammal with an effective amount of an antibody that binds to CD20, optionally also with another agent that...
US20050276756 Compositions as adjuvants to improve immune responses to vaccines and methods of use  
The invention provides compositions containing an antigen and a TIM targeting molecule. The invention additionally provides a TIM targeting molecule conjugate, for example, a TIM targeting...
US20050226940 Antitumour compositions containing taxane derivatives  
Antitumour combinations consisting of taxol or Taxotère or analogues thereof combined with at least one therapeutically useful substance for treating neoplastic diseases.
US20050186208 Treatment with anti-VEGF antibodies  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20050074451 Methods and compositions for treating rheumatoid arthritis  
This application relates to methods and compositions for treating rheumatoid arthritis by administering a combination therapy comprising methotrexate and an antibody to alpha-4 integrin or an...
US20120238938 METHOD AND APPARATUS FOR THE DELIVERY OF PHOTO-CHEMICAL (CROSS-LINKING) TREATMENT TO CORNEAL TISSUE  
Systems and methods for delivering and infusing formulations containing riboflavin or its analogues, or other ophthalmic formulations, into corneal tissue are disclosed. Systems and methods are...
US20110152219 USE OF ENHANCERS, POSSIBLY ASSOCIATED TO RIBOFLAVIN, AS WELL AS CORRESPONDING OPHTHALMIC COMPOSITIONS FOR CORNEAL CROSS-LINKING IN THE TREATMENT OF THE KERATOCONUS OR OF OTHER CORNEAL ECTASIC DISORDERS  
The use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by the method of corneal cross-linking.
US20070148178 TREATMENT WITH ANTI-VEGF ANTIBODIES  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20070071749 TREATMENT WITH ANTI-VEGF ANTIBODIES  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20070071748 TREATMENT WITH ANTI-VEGF ANTIBODIES  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20070036790 TREATMENT WITH ANTI-VEGF ANTIBODIES  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20070036754 TREATMENT WITH ANTI-VEGF ANTIBODIES  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20070036753 TREATMENT WITH ANTI-VEGF ANTIBODIES  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20070031413 TREATMENT WITH ANTI-VEGF ANTIBODIES  
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients...
US20060280738 Anti-CD19 antibody therapy for transplantation  
The invention relates to immunotherapeutic compositions and methods for the treatment and prevention of GVHD, humoral rejection, and post-transplantation lymphoproliferative disorder in human...
US20060127445 Anti-angiogenic compositions and methods of use  
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic...
US20060063728 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease  
The present invention includes compositions and methods for the treatment of inflammatory disease (e.g., asthma, COPD, inflammatory bowel disease, atopic dermatitis, atopy, allergy, allergic...
US20060029585 Methods for reducing morbidity  
Various compositions containing transfer factor in combination with nutraceuticals are provided including transfer factor in combination with zinc and essential fatty acids and transfer factor in...
US20050032715 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds  
The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease...
US20060217386 Nutritional preparations  
Compositions and methods for improving the nutritional and physiological status of a woman and her child during all stages of pregnancy are provided herein. This includes pre-conceptional women,...
US20050281794 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds  
The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease...
US20050147665 Pharmaceutical and nutritional compositions  
The combined application of at least one essential fatty acid of the n-6 or n-3 series, optionally together with further essential fatty acid(s) of the n-6 or n-3 series, together with one or more...
US20050025712 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma  
Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in...
US20150173991 METHOD AND APPARATUS FOR DERMATOLOGICAL TREATMENT  
Exemplary methods and systems can be provided for resurfacing of skin that include formation of a plurality of small holes, e.g., having widths greater than about 0.2 mm and less than about 0.7 mm...
US20060233810 Methods and compositions for treating or preventing cancer  
This invention relates to compositions and methods useful for treating various cancers. Therapeutic combinations and methods of use thereof are also covered in the present application.
US20060121117 Anti-angiogenic compositions and methods of use  
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic...
US20060074088 Dihydropteridinones for the treatment of cancer diseases  
Disclosed is the use of a compound of general Formula (1), optionally in form of its tautomers, racemates, enantiomers, diastereomers and the mixtures thereof and optionally in form of the...
US20050249713 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract  
Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine...
US20050196434 Pharmaceutical composition and method for the transdermal delivery of magnesium  
The present invention relates to a method and transdermal pharmaceutical composition for preventing magnesium deficiency or imbalances associated with magnesium deficiency including diabetes,...
US20080152585 Low viscosity liquid dosage forms  
The present invention relates to liquid dosage forms of nanoparticulate active agents having very low viscosities.

Matches 1 - 50 out of 363 1 2 3 4 5 6 7 8 >